miR Scientific, LLC is a precision bioscience company committed to improving public health by transforming cancer management globally. The Company has developed the miR Scientific Sentinel Prostate Assay that offers a non-invasive liquid biopsy urine test that accurately detects and precisely classifies prostate cancer at the molecular level with industry-leading Sensitivity and Specificity. Our molecular diagnostic capabilities approach cancer detection, classification, and monitoring through a new lens with advanced sncRNA interrogation techniques, a proprietary scoring algorithm, and innovative clinical decision support tools.